Diabetes Insipidus clinical trials
The registry lists 191 studies for Diabetes Insipidus across more than 10 countries. 35 are recruiting or about to start. 50 of them are mainly about Diabetes Insipidus (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Diabetes Insipidus, Neurogenic too: 205 studies, 40 open.
Get an email when these change. Save the Diabetes Insipidus studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University Hospital, Basel, Switzerland (25) · University of Electronic Science and Technology of China (7) · Region Skane (3) · Washington University School of Medicine (3) · Otsuka Pharmaceutical Development & Commercialization, Inc. (3) · Charite University, Berlin, Germany (3) · National Center for Research Resources (NCRR) (3) · National Institute of Mental Health (NIMH) (3)
What is being tested here
Drugs under test in Diabetes Insipidus studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Aug 2027Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis · Phase 3 · Hospital do Coracao
- Dec 2026Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study · Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- Dec 2026Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face Attention · University of Electronic Science and Technology of China
- Dec 2026Vasopressin and Pain Perception in the Brain · University of Maryland, Baltimore
- Dec 2026The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU · Children's Hospital of Fudan University
- Feb 2027Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency · University Hospital, Basel, Switzerland
- Feb 2027Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls · University Hospital, Basel, Switzerland
- Mar 2027CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial · Jason Sperry
- Apr 2027Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study · Washington University School of Medicine
- Apr 2027Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis · University Hospital, Basel, Switzerland
Who these studies take
Of the 30 Diabetes Insipidus studies recruiting now, 16 (53%) set no upper age limit and 11 (37%) stop at 75 or younger. 4 (13%) take children under 18. 1 (3%) are for women only and 1 (3%) for men only; 10 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (10%) | 3 (10%) |
| 18 | 26 (87%) | 27 (90%) |
| 30 | 25 (83%) | 25 (83%) |
| 40 | 23 (77%) | 23 (77%) |
| 50 | 21 (70%) | 22 (73%) |
| 65 | 20 (67%) | 20 (67%) |
| 75 | 19 (63%) | 19 (63%) |
| 85 | 18 (60%) | 18 (60%) |
Across all 191 studies, recruiting or not: 38% stop at 75 or younger and 33% at 65; 16% take children; 7% are for women only and 4% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Diabetes Insipidus studies take
Of 37 interventional studies with no phase under Diabetes Insipidus, half reached primary completion within 20 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 20 mo8–44 · 37 studies | — | 20 mo8–44 · 37 studies |
| Observational | 24 mo14–55 · 23 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 14, 2026.
Started recruiting1
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 191. Browse all 191 → or search them.
- VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical TrialRecruitingNCT05139849Phase 31 country
- The Effects of Increased Water Intake on Muscle Function, Physical Performance, and Endocrine Regulation in Low-Drinking Older AdultsRecruitingNCT07892742Not applicable1 country
- Biological Profiles of Neuropeptides, Neurotrophins and miRNA in MigraineEnrolling by invitationNCT078320321 country
- CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) TrialRecruitingNCT05958342Phase 21 country
- Vasopressin and Pain Perception in the BrainRecruitingNCT03446456Phase 1/21 country
- A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the BodyRecruitingNCT07525960Phase 11 country
- Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face AttentionRecruitingNCT07838493Not applicable1 country
- Early Versus Late Adjunctive Vasopressin in Septic ShockRecruitingNCT06709573Phase 41 country
- A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaRecruitingNCT06368817Phase 23 countries
- Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-DeficiencyRecruitingNCT07361263Not applicable1 country
- Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic ShockNot yet recruitingNCT076971441 country
- Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeRecruitingNCT07569861Not applicable1 country
- Oxytocin Substitution Therapy in Patients With Central Diabetes InsipidusRecruitingNCT06036004Phase 23 countries
- Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro StudyRecruitingNCT04053478Not applicable1 country
- Serum Copeptin as Biomarker for Diagnosis and Classification of Polyuric Primary Monosymptomatic Nocturnal EnuresisNot yet recruitingNCT07496541
- Tranexamic Acid vs Vasopressin in Placenta Previa TrialNot yet recruitingNCT07423156Phase 31 country
- The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICURecruitingNCT067420601 country
- Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation TechnologyRecruitingNCT07276152Not applicable1 country
- Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent SepsisRecruitingNCT06464510Phase 31 country
- Vasoactive Drugs in Intensive Care UnitRecruitingNCT02118467Phase 41 country
- Weaning Approaches for Vasopressin in SepsisRecruitingNCT07067866Phase 31 country
- Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical StudyRecruitingNCT028415531 country
- The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCARecruitingNCT06203847Not applicable1 country
- Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress SyndromeRecruitingNCT071541341 country
- Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate AntidiuresisRecruitingNCT06821802Not applicable1 country
- HYdrocortisone and VAsopressin in Post-RESuscitation SyndromeRecruitingNCT04591990Phase 31 country
- Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy ControlsRecruitingNCT06676774Phase 21 country
- Registry of Patients in Shock Treated With VasopressinRecruitingNCT064229751 country
- Saline Infusion Test in HyponatremiaNot yet recruitingNCT06498856
- Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic ShockRecruitingNCT06471231Phase 41 country
- Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking StudyRecruitingNCT06329063Not applicable1 country
- The Effects of Oral Vasopressin on Attention Control: An Eye-tracking StudyRecruitingNCT06329037Not applicable1 country
- Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill PatientsRecruitingNCT06265259Phase 41 country
- Common and Differentiated Representations Between Social Exclusion and Social SeparationRecruitingNCT05920707Not applicable1 country
- The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock PatientsRecruitingNCT05886192Phase 41 country
- Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College StudentsCompletedNCT06259799Not applicable1 country
- I-Tracking Neurodegeneration in Early Wolfram SyndromeCompletedNCT039512981 country
- Copeptin and Acute Coronary Syndrome Without ST-segment ElevationCompletedNCT01334645Not applicable1 country
- Vasopressin for Septic Shock Pragmatic TrialCompletedNCT06217562Phase 41 country
- Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00201994Phase 31 country
- "SALT Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00072683Phase 31 country
- Multimodal Vasopressor Strategy in Septic ShockCompletedNCT06155812Phase 2/32 countries
- Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure VariationActive, not recruitingNCT074389251 country
- Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium AdministrationCompletedNCT05190744Phase 21 country
- Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)CompletedNCT04897802Phase 41 country
- Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)CompletedNCT06542198Not applicable1 country
- Hydration to Optimize MetabolismCompletedNCT03422848Not applicable1 country
- Potential Benefits of the Somatic Psychoeducational InterventionCompletedNCT05766852Not applicable1 country
- The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency CouplingCompletedNCT06605300Not applicable1 country
- Rectal Misoprostol as a Hemostatic Agent During Abdominal MyomectomyCompletedNCT03064568Phase 41 country